US FDA declines to approve Scholar Rock's muscle weakness drug

Scholar Rock Holding

23/09/2025 12:04

Sept 23 (Reuters) - The U.S. Food and Drug Administration has declined to approve Scholar Rock's SRRK.O drug for a rare neuromuscular disease, citing issues at a third party manufacturing facility, the company said on Tuesday.

 (Reporting by Sriparna Roy in Bengaluru; Editing by Shailesh Kuber)

 ((Sriparna.Roy@thomsonreuters.com;))